These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35411052)

  • 61. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
    Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
    Front Immunol; 2022; 13():937555. PubMed ID: 35812394
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
    van der Zee S; Vermeiren Y; Fransen E; Van Dam D; Aerts T; Gerritsen MJ; Spikman JM; van Laar T; De Deyn PP
    J Parkinsons Dis; 2018; 8(1):71-84. PubMed ID: 29480224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.
    Zhou ZL; Jia XB; Sun MF; Zhu YL; Qiao CM; Zhang BP; Zhao LP; Yang Q; Cui C; Chen X; Shen YQ
    Neurotherapeutics; 2019 Jul; 16(3):741-760. PubMed ID: 30815845
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
    Baldini F; Hertel J; Sandt E; Thinnes CC; Neuberger-Castillo L; Pavelka L; Betsou F; Krüger R; Thiele I;
    BMC Biol; 2020 Jun; 18(1):62. PubMed ID: 32517799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies.
    Lubomski M; Xu X; Holmes AJ; Muller S; Yang JYH; Davis RL; Sue CM
    Front Aging Neurosci; 2022; 14():875261. PubMed ID: 35656540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism.
    Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G
    Mov Disord; 2019 Mar; 34(3):396-405. PubMed ID: 30576008
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment.
    Shang J; Ma S; Zang C; Bao X; Wang Y; Zhang D
    Acta Pharm Sin B; 2021 May; 11(5):1213-1226. PubMed ID: 34094829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study.
    Vascellari S; Melis M; Cossu G; Melis M; Serra A; Palmas V; Perra D; Oppo V; Fiorini M; Cusano R; Morelli M; Manzin A; Barbarossa IT
    Int J Biol Macromol; 2020 Dec; 165(Pt A):665-674. PubMed ID: 32946938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease.
    Chung SJ; Rim JH; Ji D; Lee S; Yoo HS; Jung JH; Baik K; Choi Y; Ye BS; Sohn YH; Yun M; Lee SG; Lee PH
    Nutrition; 2021 Mar; 83():111090. PubMed ID: 33418492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
    Romo-Vaquero M; Fernández-Villalba E; Gil-Martinez AL; Cuenca-Bermejo L; Espín JC; Herrero MT; Selma MV
    Food Funct; 2022 Jun; 13(11):6306-6316. PubMed ID: 35611932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
    Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
    J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study.
    Fang Y; Zhang C; Shi H; Wei W; Shang J; Zheng R; Yu L; Wang P; Yang J; Deng X; Zhang Y; Tang S; Shi X; Liu Y; Yang H; Yuan Q; Zhai R; Yuan H
    Diabetes Care; 2021 Dec; 44(12):2738-2746. PubMed ID: 34620611
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Gut Microbiota in the Progression of Parkinson's Disease and the Mechanism of Intervention by Traditional Chinese Medicine.
    Huan P; Wang L; He Z; He J
    Neuropsychiatr Dis Treat; 2022; 18():1507-1520. PubMed ID: 35923300
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The relationship between Parkinson's disease and gastrointestinal diseases.
    Zeng J; Wang X; Pan F; Mao Z
    Front Aging Neurosci; 2022; 14():955919. PubMed ID: 36034146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.